Photo of Antonina  Kuzmis

Antonina Kuzmis


Graduate Program Coordinator, Biopharmaceutical Sciences

Contact

Building & Room:

335

Address:

833 S. Wood Street, Chicago, IL, 60612

Office Phone:

(312) 413-3708

Office Phone TTY:

(312) 996-0098

Selected Publications

  • Khaja F, Jayawardena D, Kuzmis A, Önyüksel H. Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis.. Nanomaterials (Basel, Switzerland). 2016;6(1). doi:10.3390/nano6010008.
  • Vuković L, Madriaga A, Kuzmis A, Banerjee A, Tang A, Tao K, Shah N, Král P, Onyuksel H. Solubilization of therapeutic agents in micellar nanomedicines.. Langmuir : the ACS journal of surfaces and colloids. 2013;29(51):15747-54. doi:10.1021/la403264w.
  • Gülçür E, Thaqi M, Khaja F, Kuzmis A, Onyuksel H. Curcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: a novel therapeutic approach for breast cancer and breast cancer stem cells.. Drug delivery and translational research. 2013;3(6). doi:10.1007/s13346-013-0167-6.
  • Sethi V, Rubinstein I, Kuzmis A, Kastrissios H, Artwohl J, Onyuksel H. Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis.. Molecular pharmaceutics. 2013;10(2):728-38. doi:10.1021/mp300539f.
  • Dagar A, Kuzmis A, Rubinstein I, Sekosan M, Onyuksel H. VIP-targeted Cytotoxic Nanomedicine for Breast Cancer.. Drug delivery and translational research. 2012;2(6):454-62. doi:10.1007/s13346-012-0107-x.
  • Kuzmis A, Lim S, Desai E, Jeon E, Lee B, Rubinstein I, Onyuksel H. Micellar nanomedicine of human neuropeptide Y.. Nanomedicine : nanotechnology, biology, and medicine. 2011;7(4):464-71. doi:10.1016/j.nano.2011.01.004.